ctrl K

Watchlist Price Alert

Virax Biolabs Group Limit... (VRAX)

NASDAQ: VRAX · Real-Time Price · USD

0.83

-0.04 (-4.63%)

At close: Jun 17, 2025, 3:58 PM

0.82

-0.97%

After-hours: Jun 17, 2025, 07:03 PM EDT

Virax Biolabs Balance Sheet Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	3.59M	9.35M	21.76K	17.62K	22.61K
Short-Term Investments	77.32K	49.26K	6K	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	54.5K	n/a
Other Long-Term Assets	-49.77K	-178.4K	n/a	n/a	n/a
Receivables	217.84K	n/a	n/a	928.00	n/a
Inventory	60.38K	24.09K	20.95K	21.07K	n/a
Other Current Assets	77.32K	n/a	n/a	n/a	n/a
Total Current Assets	4.38M	9.63M	48.71K	39.62K	22.61K
Property-Plant & Equipment	1.1M	n/a	n/a	n/a	n/a
Goodwill & Intangibles	49.77K	178.4K	n/a	n/a	n/a
Total Long-Term Assets	1.1M	178.4K	n/a	54.5K	n/a
Total Assets	5.48M	9.81M	48.71K	94.12K	22.61K
Account Payables	45.63K	159.91K	846.47K	217.15K	212.84K
Deferred Revenue	n/a	38.25K	-0.00	n/a	-759.37K
Short-Term Debt	n/a	146.25K	n/a	n/a	759.37K
Other Current Liabilities	63.12K	140.29K	3.76K	192K	11.47K
Total Current Liabilities	168.85K	908.4K	1.25M	871.43K	1.24M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	176.34K	n/a	n/a	n/a	n/a
Total Liabilities	345.19K	908.4K	1.25M	871.43K	1.24M
Total Debt	224.3K	146.25K	3.76K	179.48K	759.37K
Common Stock	2.57K	1.56K	999.00	265.00	104.00
Retained Earnings	-18.53M	-11.79M	-6.34M	-4.63M	-3.98M
Comprehensive Income	23.89M	20.92M	5.36M	4.03M	2.92M
Shareholders Equity	5.37M	9.13M	-974.58K	-596.18K	-1.06M
Total Investments	77.32K	49.26K	6K	54.5K	n/a